Boston Scientific announces pricing of €1.5 billion of senior notes

Core Viewpoint - Boston Scientific Corporation announced a public offering of €850 million in 3.000% notes due 2031 and €650 million in 3.250% notes due 2034, fully guaranteed by the company [1][2] Group 1: Offering Details - The total amount of the offering is €1.5 billion, consisting of two tranches of notes [1] - The offering is expected to close on February 26, 2025, subject to customary closing conditions [2] - The notes will be used to repay AMS Europe's 0.750% senior notes due March 8, 2025, and for general corporate purposes [2] Group 2: Company Overview - Boston Scientific has been a global medical technology leader for over 45 years, focusing on innovative medical technologies that improve patient health [4] - The company provides a wide range of solutions addressing various medical conditions, including cardiovascular, respiratory, digestive, oncological, neurological, and urological diseases [4]